계명대학교 의학도서관 Repository

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma

Metadata Downloads
Author(s)
Junshik HongSeok Jin KimMyung Hee ChangJeong-A KimJae-Yong KwakJin Seok KimDok Hyun YoonWon Sik LeeYoung Rok DoHye Jin KangHyeon-Seok EomYong ParkJong-Ho WonYeung-Chul MunHyo Jung KimJung Hye KwonJee Hyun KongSung Yong OhSunah LeeSung Hwa BaeDeok-Hwan YangHyun Jung JunHo Sup LeeHwan Jung YunSoon Il LeeMin Kyoung KimJun Ho YiJae Hoon LeeWon Seog KimCheolwon Suh
Keimyung Author(s)
Do, Young Rok
Department
Dept. of Internal Medicine (내과학)
Journal Title
Oncotarget
Issued Date
2017
Volume
8
Issue
54
Keyword
diffuse large B-cell lymphomainternational prognostic indexnon-hodgkin lymphomaoverall survivalprognosis
Abstract
The National Comprehensive Cancer Network (NCCN)-International Prognostic Index (IPI) and GELTAMO (Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea)-IPI were developed to enable better risk prediction of patients with diffuse large B-cell lymphoma (DLBCL). The present study compared the effectiveness of risk prediction between IPI, NCCN-IPI, and GELTAMO-IPI in patients with DLBCL particularly in terms of determining high-risk patients. Among 439 patients who were enrolled to a prospective DLBCL cohort treated with R-CHOP immunochemotherapy, risk groups were classified according to the three IPIs and the prognostic significance of individual IPI factors and IPI models were analyzed and compared. All three IPI effectively separated the analyzed patients into four risk groups according to overall survival (OS). Estimated 5-year OS of patients classified as high-risk according to the IPI was 45.7%, suggesting that the IPI is limited in the selection of patients who are expected to have a poor outcome. In contrast, the 5-year OS of patients stratified as high-risk according to NCCN- and GELTAMO-IPI was 31.4% and 21.9%, respectively. The results indicate that NCCN- and GELTAMO-IPI are better than the IPI in predicting patients with poor prognosis, suggesting the superiority of enhanced, next-generation IPIs for DLBCL.
Keimyung Author(s)(Kor)
도영록
Publisher
School of Medicine (의과대학)
Citation
Junshik Hong et al. (2017). Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma. Oncotarget, 8(54), 92171–92182. doi: 10.18632/oncotarget.20988
Type
Article
ISSN
1949-2553
DOI
10.18632/oncotarget.20988
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/41297
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.